The Diaceutics Podcast

We estimate there's a 100% chance this podcast is looking for guests- reach out and make your move!

Topic Category:

Science

Topic Sub-Category:

Life Sciences

Where to Listen:

Language:

English

Copyright Notice:

Podcast Stats:

Number of Episodes: 1

Series Type: episodic

Content Type: AUDIO

Podcast Description

🎙️ The Diaceutics Podcast: Diagnostics, Data & Commercial Strategy

Welcome to The Diaceutics Podcast — where diagnostics meet data, and strategy meets impact.

In each episode, we explore how Diaceutics is helping pharma and biotech companies navigate the complex journey from biomarker discovery to therapy adoption. Whether it’s oncology, rare disease, or emerging therapeutic areas, we dive into the real-world challenges and innovations shaping the future of healthcare.

From diagnostic testing and commercialization to AI, real-time data, and global market access — this is your front-row seat to the evolving world of precision-driven healthcare.

www.diaceutics.com

Podcast Insights

Content Themes

The podcast covers a variety of themes central to precision medicine, including diagnostic testing, AI in healthcare, and therapeutic strategy. Notable episode examples include insights from ASCO 2025 focusing on actionable strategies for pharma teams, the impact of novel therapies like gene and cell therapies, and advances in ctDNA detection methods.

Further Podcast insights, such as show format, guest types, ideal guests, and target audience are available to Podcast Collab Club Members!

The Diaceutics Podcast

🎙️ The Diaceutics Podcast: Diagnostics, Data & Commercial Strategy

Welcome to The Diaceutics Podcast — where diagnostics meet data, and strategy meets impact.

In each episode, we explore how Diaceutics is helping pharma and biotech companies navigate the complex journey from biomarker discovery to therapy adoption. Whether it’s oncology, rare disease, or emerging therapeutic areas, we dive into the real-world challenges and innovations shaping the future of healthcare.

From diagnostic testing and commercialization to AI, real-time data, and global market access — this is your front-row seat to the evolving world of precision-driven healthcare.

www.diaceutics.com

Join Susanne Munksted, Chief Precision Medicine Officer at Diaceutics, and Kevin Entwistle, VP of Precision Medicine Strategy, as they unpack the key takeaways from ASCO 2025 and explore how the latest oncology data can shape your commercial strategy.

In this expert-led discussion, you’ll hear about:

How to translate scientific insights into actionable strategies for pharma and biotech teams
Commercial implications of novel ADCs, gene & cell therapies, and multi-cancer detection
The growing impact of AI and computational pathology in clinical decision-making
Breakthrough clinical data from trials like SERENA-6, MATTERHORN, ATOMIC, and AMPLITUDE
Advances in ctDNA and MRD detection, including MONSTAR-SCREEN-3 and DYNAMIC-III
The evolving role of biomarkers and diagnostic testing in precision medicine

Connect with the Speakers

Susanne Munksted: https://www.linkedin.com/in/susanne-munksted-9169031/
Kevin Entwistle: https://www.linkedin.com/in/kevin-entwistle-73335520/

🌐 Learn more about Diaceutics: https://www.diaceutics.com/contact-us

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.

For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.